Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Clinical trial NCT07521332 · RECRUITING

Trial details

NCT number: NCT07521332
Sponsor: Asian Institute Of Medical Sciences
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cirrhosis Esophageal and Gastric Varices Ascites Hepatic Encephalopathy Portal Vein Thrombosis Portal Hypertension

Start date: 2026-04-01
Primary completion: 2027-04-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.